“…To investigate the role of miR-532-5p in neuroinflammation, we further detected the inflammatory cytokines in mice exposed to CUMS. Compared with the control group, the expression of iNOS in the hippocampus of CUMS mice was increased significantly (ANOVA, F (3,20) = 60.002, p = 0.000; LSD test, t =−11.757, p = 0.000) (p < 0.01, Figure 3A and B), and overexpression of miR-532-5p significantly inhibited the increased expression of iNOS (ANOVA, F (3,20) = 60.002, p = 0.000; LSD test, t =7.821, p = 0.000) (p < 0.01, Figure 3A and B). The expression of IL-6, IL-1β, TNF-α and MCP-1 in hippocampus of CUMS mice were significantly increased (IL-6, ANOVA, F (3,20) = 72.672, p = 0.000; LSD test, t =−11.763, p = 0.000; IL-1.0 ANOVA, F (3,20) = 29.012, p = 0.000; LSD test, t =−7.531, p = 0.000; TNF-., ANOVA, F (3,20) = 21.476, p = 0.000; LSD test, t =−7.485, p = 0.000; MCP-1, ANOVA, F (3,20) = 99.092, p = 0.000; LSD test, t =−7.485, p = 0.000)(p < 0.01, Figure 3B-E), while miR-532-5p overexpression significantly inhibited the increased expression of cytokines (IL-6, ANOVA, F (3,20) = 72.672, p = 0.000; LSD test, t =4.555, p = 0.010; IL-1β, ANOVA, F (3,20) = 29.012, p = 0.000; LSD test, t = 4.717, p = 0.001; TNF-α, ANOVA, F (3,20) = 21.476, p = 0.000; LSD test, t =3.145, p = 0.035; MCP-1, ANOVA, F (3,20) = 99.092, p = 0.000; LSD test, t =3.600, p = 0.023) (p < 0.05, p < 0.01, Figure 3B-E).…”